An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request